Skip to content

AI based Microscopy

A Prospective Observational Multicentric Clinical Trial to evaluate microscopic examination of various clinical samples by Artificial Intelligence based system - AI Microscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032726
Enrollment
1600
Registered
2021-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D649- Anemia, unspecified Health Condition 2: B359- Dermatophytosis, unspecified Health Condition 3: A159- Respiratory tuberculosis unspecified Health Condition 4: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

Sevamob Ventures Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria for superficial fungal infections: The patients visiting the skin outpatient department (OPD) in the hospital settings and suspected of fungal infections in skin or hair or nail by the dermatologist. 2.Inclusion Criteria for community acquired lower Urinary Tract Infection (UTI): All the patients of symptomatic UTI �18 years old from community with complaints of burning micturition and urgency. And not been admitted into the hospital for more than 48 hours in previous 1 month. 3.Inclusion criteria for Blood smear examination: We will include 400 patients who are coming for routine Complete blood count (CBC) evaluation in haematology unit of Department of Pathology. Consent will be taken from the patient/ patient attendant when they will come for routine CBC in hematology lab. 4.Inclusion criteria for pulmonary tuberculosis: Cases of suspected pulmonary tuberculosis whose sputum samples are submitted for AFB microscopy.

Exclusion criteria

Exclusion criteria: 1.Exclusion criteria for superficial fungal infections: Patients on antifungal therapy (oral as well as topical) for last 2ââ?¬â??3 months. Patients with documented bacterial skin infections. 2.Exclusion Criteria: Patients who had been on antibiotics 2 weeks or earlier prior to the study. Patients on phenazopyridine use in the prior 2 day, or with symptoms or signs of pyelonephritis, recent catheterization, or known anatomic or functional abnormalities of the urinary tract. 3.Exclusion criteria: All the patients of Aplastic anaemia, patients on chemotherapy and radiotherapy. 4.Exclusion criteria: Extra pulmonary tuberculosis, children/patients unable to expectorate sputum, patients unwilling to give consent.

Design outcomes

Primary

MeasureTime frame
AI is equivalent to conventional microscopyTimepoint: AI is equivalent to conventional microscopy

Secondary

MeasureTime frame
NoneTimepoint: None

Countries

India

Contacts

Public ContactVijay Kumar Sonkar

King George Medical University shah mina road Lucknow

prashantgupta46@hotmail.com9140032177

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026